MedPath

MYLAN PHARMACEUTICALS INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
36
Registration Number
NCT00649662
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

Phase 1
Completed
Conditions
Therapeutic Equivalency
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
44
Registration Number
NCT00648544
Locations
🇨🇦

Biovail Contract Reseach, Toronto, Ontario, Canada

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
64
Registration Number
NCT00649402
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
28
Registration Number
NCT00647751
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
35
Registration Number
NCT00648661
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
40
Registration Number
NCT00650533
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
53
Registration Number
NCT00648778
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg

First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT00649688
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-04-01
Last Posted Date
2024-04-24
Lead Sponsor
Mylan Pharmaceuticals Inc
Target Recruit Count
32
Registration Number
NCT00647777
Locations
🇺🇸

Kendle International Inc., Morgantown, West Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath